• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非ST段抬高型心肌梗死中的心脏T1映射:心肌纤维化的时间变化

Cardiac T1 mapping in non-ST-segment elevation myocardial infarction: temporal changes in myocardial fibrosis.

作者信息

Paiva Luis, Ferreira Maria João, Afonso Sónia, Donato Paulo, Gonçalves Lino

机构信息

Centro Académico e Clínico de Coimbra (CACC), Coimbra, Portugal.

Coimbra Institute for Clinical and Biomedical Research (iCBR), Universidade de Coimbra, Coimbra, Portugal.

出版信息

Front Cardiovasc Med. 2025 May 23;12:1563368. doi: 10.3389/fcvm.2025.1563368. eCollection 2025.

DOI:10.3389/fcvm.2025.1563368
PMID:40486822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141208/
Abstract

INTRODUCTION

Cardiac magnetic resonance (CMR) imaging allows tracking of ongoing fibrosis modifications following myocardial infarction (MI). We evaluated temporal changes in late gadolinium enhancement (LGE) and extracellular volume fraction (ECV) within the MI culprit coronary artery and remote regions of the myocardium during the index ischemic event and follow-up in patients with NSTEMI.

METHODS

This prospective, single-center study included 30 patients with type 1 NSTEMI. It involved the evaluation of patients using coronary angiography, invasive coronary physiology, and biomarkers. CMR imaging was used to assess left ventricular (LV) volume, function, and myocardial fibrosis using LGE and ECV. These assessments were performed at baseline and repeated 6-10 months after MI.

RESULTS

At the 4-year post-MI follow-up, 27 patients survived [age 65 (58,74) years; 77% male], and LV mass, volume, and contractility remained unchanged between the baseline and follow-up measurements. Myocardial fibrosis assessed using LGE showed a decreasing trend at follow-up (9.4 ± 4.4% vs. 6.7 ± 4.4%;  = 0.051), particularly in the MI culprit coronary artery regions (14.2 ± 8.6% vs. 9.5 ± 7.0%;  = 0.015). LGE volume regression was observed in 70% of cases. The ECV measurements did not change between the initial and follow-up CMR assessments. Despite the high prevalence of multivessel coronary artery disease (CAD) (53%), no significant changes in LGE or ECV measurements were observed in the remote myocardium.

CONCLUSIONS

After NSTEMI, LGE decreased in the heart regions supplied by the culprit coronary arteries. However, the ECV measurements remained unchanged. Multivessel CAD was not associated with significant changes in myocardial fibrosis in the remote myocardium.

摘要

引言

心脏磁共振成像(CMR)能够追踪心肌梗死(MI)后持续的纤维化改变。我们评估了非ST段抬高型心肌梗死(NSTEMI)患者在首次缺血事件期间及随访过程中,梗死相关冠状动脉及心肌远隔区域的延迟钆增强(LGE)和细胞外容积分数(ECV)的时间变化。

方法

这项前瞻性单中心研究纳入了30例1型NSTEMI患者。研究包括使用冠状动脉造影、有创冠状动脉生理学和生物标志物对患者进行评估。CMR成像用于通过LGE和ECV评估左心室(LV)容积、功能和心肌纤维化。这些评估在基线时进行,并在MI后6 - 10个月重复进行。

结果

在MI后4年的随访中,27例患者存活[年龄65(58,74)岁;77%为男性],LV质量、容积和收缩性在基线和随访测量之间保持不变。使用LGE评估的心肌纤维化在随访时呈下降趋势(9.4±4.4%对6.7±4.4%;P = 0.051),特别是在梗死相关冠状动脉区域(14.2±8.6%对9.5±7.0%;P = 0.015)。70%的病例观察到LGE容积缩小。初始和随访CMR评估之间ECV测量值没有变化。尽管多支冠状动脉疾病(CAD)的患病率很高(53%),但在心肌远隔区域LGE或ECV测量值没有观察到显著变化。

结论

NSTEMI后,梗死相关冠状动脉供血的心脏区域LGE降低。然而,ECV测量值保持不变。多支CAD与心肌远隔区域心肌纤维化的显著变化无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/4fa76a37e966/fcvm-12-1563368-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/c854771f7ba3/fcvm-12-1563368-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/f6af13781d40/fcvm-12-1563368-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/4fa76a37e966/fcvm-12-1563368-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/c854771f7ba3/fcvm-12-1563368-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/f6af13781d40/fcvm-12-1563368-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e67/12141208/4fa76a37e966/fcvm-12-1563368-g003.jpg

相似文献

1
Cardiac T1 mapping in non-ST-segment elevation myocardial infarction: temporal changes in myocardial fibrosis.非ST段抬高型心肌梗死中的心脏T1映射:心肌纤维化的时间变化
Front Cardiovasc Med. 2025 May 23;12:1563368. doi: 10.3389/fcvm.2025.1563368. eCollection 2025.
2
Myocardial Extracellular Volume Fraction Allows Differentiation of Reversible Versus Irreversible Myocardial Damage and Prediction of Adverse Left Ventricular Remodeling of ST-Elevation Myocardial Infarction.心肌细胞外容积分数有助于鉴别可逆性与不可逆性心肌损伤,并预测ST段抬高型心肌梗死患者左心室不良重构。
J Magn Reson Imaging. 2020 Aug;52(2):476-487. doi: 10.1002/jmri.27047. Epub 2020 Jan 14.
3
Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI.CMR 估算心肌细胞外容积可预测急性心肌梗死后的功能恢复。
JACC Cardiovasc Imaging. 2017 Sep;10(9):989-999. doi: 10.1016/j.jcmg.2016.06.015. Epub 2016 Oct 19.
4
Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.基于T1映射和细胞外容积分数(ECV)测量的肌营养不良患者心肌纤维化成像:与传统钆延迟增强(LGE)成像相比的诊断价值
Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1004-12. doi: 10.1093/ehjci/jeu050. Epub 2014 Mar 30.
5
T-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T.3T 下杜氏肌营养不良症患儿与健康对照者的 T 映射和细胞外容积评估。
J Cardiovasc Magn Reson. 2020 Dec 10;22(1):85. doi: 10.1186/s12968-020-00687-z.
6
Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping.应用心血管磁共振钆延迟增强及 T1 mapping 技术检测及评估艾森曼格综合征患者心肌纤维化
J Cardiovasc Magn Reson. 2022 Nov 21;24(1):60. doi: 10.1186/s12968-022-00880-2.
7
Prognostic impact of remote myocardium changes using T1 mapping in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者中利用T1映射评估远隔心肌改变的预后影响
Eur Radiol. 2025 Jun 4. doi: 10.1007/s00330-025-11711-0.
8
Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.在无延迟强化情况下心肌病中心肌纤维化的早期检测:T1 映射和细胞外容积分析的作用
Eur Radiol. 2023 Mar;33(3):1982-1991. doi: 10.1007/s00330-022-09147-x. Epub 2022 Oct 14.
9
Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.磁共振成像的细胞外容积成像是洞察显性和亚临床心肌病理学的一种手段。
Eur Heart J. 2012 May;33(10):1268-78. doi: 10.1093/eurheartj/ehr481. Epub 2012 Jan 24.
10
Cardiovascular magnetic resonance imaging of functional and microstructural changes of the heart in a longitudinal pig model of acute to chronic myocardial infarction.心脏在急性至慢性心肌梗死的纵向猪模型中心功能和微观结构变化的心血管磁共振成像。
J Cardiovasc Magn Reson. 2021 Sep 20;23(1):103. doi: 10.1186/s12968-021-00794-5.

本文引用的文献

1
Inflammation in acute myocardial infarction: the good, the bad and the ugly.急性心肌梗死中的炎症:有好有坏有丑恶。
Eur Heart J. 2024 Jan 7;45(2):89-103. doi: 10.1093/eurheartj/ehad486.
2
Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR.瑞加德松用于应激灌注 CMR的安全性、可行性和血液动力学反应。
Int J Cardiovasc Imaging. 2023 Sep;39(9):1765-1774. doi: 10.1007/s10554-023-02877-z. Epub 2023 Jun 24.
3
Microcirculation function assessment in acute myocardial infarction: A systematic review of microcirculatory resistance indices.
急性心肌梗死中的微循环功能评估:微循环阻力指数的系统评价
Front Cardiovasc Med. 2022 Nov 11;9:1041444. doi: 10.3389/fcvm.2022.1041444. eCollection 2022.
4
Detection of myocardial fibrosis: Where we stand.心肌纤维化的检测:我们目前的进展
Front Cardiovasc Med. 2022 Sep 29;9:926378. doi: 10.3389/fcvm.2022.926378. eCollection 2022.
5
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.
6
Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.成人和儿童心血管磁共振(CMR)的参考范围(“正常值”):2020 更新。
J Cardiovasc Magn Reson. 2020 Dec 14;22(1):87. doi: 10.1186/s12968-020-00683-3.
7
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
8
Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.疑似冠心病患者临床无症状性心肌纤维化的影像学评估。
J Am Coll Cardiol. 2020 Aug 25;76(8):945-957. doi: 10.1016/j.jacc.2020.06.063.
9
Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update.标准化心血管磁共振成像(CMR)协议:2020 年更新。
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17. doi: 10.1186/s12968-020-00607-1.
10
Cardiac Magnetic Resonance Left Ventricular Mechanical Uniformity Alterations for Risk Assessment After Acute Myocardial Infarction.急性心肌梗死后心脏磁共振左心室机械均一性改变与风险评估。
J Am Heart Assoc. 2019 Aug 20;8(16):e011576. doi: 10.1161/JAHA.118.011576. Epub 2019 Aug 7.